Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

FILTRAR POR:

Por tema

Trastornos del movimiento Enfermedad de Parkinson Distonía Corea y enfermedad de Huntington Ataxia Temblor y temblor esencial Mioclonía y espasmos Tics y síndrome de Tourette Síndrome de piernas inquietas Síndrome de la persona rígida Alteraciones de la marcha Espasticidad COVID-19 y Enfermedades Neurológicas Biomarcadores Demencia Diagnosis Epidemiologia Fisiopatología Síntomas cognitivos y conductales Tratamiento farmacologico Tratamiento no farmacológico

Por año

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Tratamiento no farmacológico

358 ARTíCULOS , VIENDO DEL 331 AL 345

PUBMED

Potential of drug-loaded nanoparticles for Alzheimer's disease: diagnosis, prevention and treatment

Doggui S, Dao L, Ramassamy C.

Ther Deliv. 2012 Sep;3(9):1025-7. doi: 10.4155/tde.12.84.

PUBMED

Alzheimer disease in 2020

Holtzman DM, Mandelkow E, Selkoe DJ.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a011585. doi: 10.1101/cshperspect.a011585.

PUBMED

Ethical aspects of using GPS for tracking people with dementia: recommendations for practice

Landau R, Werner S.

Int Psychogeriatr. 2012 Mar;24(3):358-66. doi: 10.1017/S1041610211001888. Epub 2011 Oct 3.

PUBMED

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease

Williams RJ, Spencer JP.

Free Radic Biol Med. 2012 Jan 1;52(1):35-45. doi: 10.1016/j.freeradbiomed.2011.09.010. Epub 2011 Sep 17.

PUBMED

Little hope for medical futility

Caplan AL.

Mayo Clin Proc. 2012 Nov;87(11):1040-1. doi: 10.1016/j.mayocp.2012.09.003.

PUBMED

Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities

Sagare AP, Deane R, Zlokovic BV.

Pharmacol Ther. 2012 Oct;136(1):94-105. doi: 10.1016/j.pharmthera.2012.07.008. Epub 2012 Jul 20.

PUBMED

Study protocol: EXERcise and cognition in sedentary adults with early-ONset dementia (EXERCISE-ON)

Hooghiemstra AM, Eggermont LH, Scheltens P, van der Flier WM, Bakker J, de Greef MH, Koppe PA, Scherder EJ.

BMC Neurol. 2012 Aug 16;12:75. doi: 10.1186/1471-2377-12-75.

PUBMED

Alzheimer's disease special thematic issue: call for papers

Georg GI, Wang S.

J Med Chem. 2012 Apr 12;55(7):2914. doi: 10.1021/jm300393h. Epub 2012 Mar 29.

PUBMED

Iron chelation and nanoparticle target delivery in the development of new multifunctional disease-modifying drugs for Alzheimer's disease

Liu G, Men P, Zhu X, Perry G.

Ther Deliv. 2012 May;3(5):571-4. doi: 10.4155/tde.12.32.

PUBMED

[Gamma-secretase inhibitors in Alzheimer's disease therapy]

Katarína S, Jan K, Kamil K, Kamil M.

Ceska Slov Farm. 2012 Jun;61(3):93-100.

PUBMED

A concept analysis about temporality and its applicability in nursing care

Caldas CP, Berterö C.

Nurs Forum. 2012 Oct-Dec;47(4):245-52. doi: 10.1111/j.1744-6198.2012.00277.x.

PUBMED

Drug repositioning for Alzheimer's disease

Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, Kearns I, Kehoe P, Mudher A, Passmore A, Shepherd N, Walsh F, Ballard C.

Nat Rev Drug Discov. 2012 Nov;11(11):833-46. doi: 10.1038/nrd3869.

PUBMED

Discontinuing donepezil or starting memantine for Alzheimer's disease

Schneider LS.

N Engl J Med. 2012 Mar 8;366(10):957-9. doi: 10.1056/NEJMe1200429.

PUBMED

Alzheimer's dementia: a brief review

Bassil N, Mollaei C.

J Med Liban. 2012 Oct-Dec;60(4):192-9.

PUBMED

Functions of Aβ, sAPPα and sAPPβ : similarities and differences

Chasseigneaux S, Allinquant B.